Preeclampsia Postpartum, Preeclampsia Severe
Conditions
Keywords
NSAIDs, Ibuprofen
Brief summary
A randomized non-inferiority trial of women with preeclampsia with severe features to determine if the addition of nonsteroidal anti-inflammatory drugs is inferior or non-inferior to standard analgesic bundles in their impact on postpartum hypertension.
Detailed description
Recently published clinical guidelines for the care of women with hypertensive disorders recommended that nonsteroidal anti-inflammatory drugs (NSAIDs) should be withheld from patients with hypertension that persists for more than one day postpartum (1). This recommendation is based in data from the general medicine literature, which suggests a role of NSAIDs in precipitating hypertension in non-pregnant adults (2,3). It may also draw from previously published case reports of post-partum hypertension that were thought to be NSAID induced (4). There has been a paucity of data from the obstetric literature to support or rebuff this recommendation. As the opioid crisis worsens in the United States, additional attention and resources have focused on limiting the use of narcotic medications. The effective employment of non-opioid analgesics has been shown to reduce narcotic use (5). Ibuprofen and other NSAIDs are the most effective and most commonly prescribed analgesics for postpartum pain, but clinicians now find themselves stuck between these recommendations and their efforts to limit unnecessary opioid prescriptions. The investigators propose a randomized controlled non-inferiority trial of women with preeclampsia comparing a postpartum analgesic protocol that includes NSAIDs, to one that excludes them. The central hypothesis is that NSAID use does not worsen hypertensive diseases of pregnancy.
Interventions
DRUGIbuprofen 600 mg
NSAID pain medication to be used in the experimental bundle for postpartum analgesia
DRUGKetorolac
NSAID analgesic to be used in the experimental bundle for postpartum analgesia in patients who underwent cesarean section
DRUGAcetaminophen
Analgesic medication to be used in both treatment arms
DRUGOxycodone
Analgesic medication to be used in both treatment arms
Sponsors
Washington University School of Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Randomized non-inferiority clinical trial
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Women at \> 23 weeks gestational age undergoing vaginal or cesarean delivery at Barnes-Jewish Hospital with: * An antepartum diagnosis of preeclampsia with severe features * Pre-eclampsia with severe features will be defined as: * Elevated blood pressure ≥ 160/110, or * Pre-eclampsia in the setting of thrombocytopenia (platelet count \< 100,000), or * Impaired liver function (AST elevated to twice upper limit of normal), or * Persistent epigastric pain, or * Renal insufficiency (serum creatinine of 1.1 mg/dl or doubling of prior value), or * Pulmonary edema, or * New onset visual disturbance or headache unresponsive to therapy.
Exclusion criteria
* NSAID allergy * Allergy to acetaminophen * Antihypertensive use in this pregnancy prior to 20 weeks gestation * Chronic kidney disease or Acute kidney injury with Creatine clearance less than 60 mL/min * Inability to obtain consent * Opioid abuse disorder * Peptic ulcer disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| postpartum antihypertensive requirements | at the end of hospitalization, up to 7 days after randomization | measurement of anti-hypertensive requirements at time of discharge |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postpartum pain scores | From randomization to 6 weeks after randomization | Evaluate the effect of NSAIDs on patient perception of pain |
| Postpartum opioid use | From randomization to 6 weeks after randomization | Compare the opioid requirements in each arm |
| Mean arterial blood pressure | From randomization to 6 weeks after randomization | Compare peak, average and median MAPs postpartum |
| End organ damage | during hospitalization, an average of 4 days | Evaluate for evidence of renal, hepatic or neurological injury in the poatpartum period |
| Hospital readmission | From randomization to 6 weeks after randomization | Evaluate the incidence of hospital readmission rate postpartum |
| Continued anti-hypertensive requirement | up to 6 weeks | evaluate the need for antihypertensive medications at 6 weeks postpartum |
Countries
United States
Outcome results
None listed